USS Investment Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.81M | Sell |
77,957
-41,692
| -35% | -$1.5M | 0.02% | 458 |
|
|
2025
Q1 | $3.72M | Sell |
119,649
-42,500
| -26% | -$1.32M | 0.03% | 386 |
|
|
2024
Q4 | $4.13M | Sell |
162,149
-64,457
| -28% | -$1.64M | 0.03% | 405 |
|
|
2024
Q3 | $6.41M | Buy |
226,606
+10,949
| +5% | +$310K | 0.05% | 353 |
|
|
2024
Q2 | $5.68M | Buy |
215,657
+10,008
| +5% | +$264K | 0.05% | 344 |
|
|
2024
Q1 | $6.25M | Buy |
205,649
+34,269
| +20% | +$1.04M | 0.05% | 324 |
|
|
2023
Q4 | $4.81M | Buy |
171,380
+37,778
| +28% | +$1.06M | 0.04% | 384 |
|
|
2023
Q3 | $3.63M | Buy |
133,602
+33,489
| +33% | +$909K | 0.04% | 429 |
|
|
2023
Q2 | $3.08M | Buy |
100,113
+5,374
| +6% | +$165K | 0.04% | 444 |
|
|
2023
Q1 | $3.41M | Buy |
94,739
+7,464
| +9% | +$269K | 0.05% | 419 |
|
|
2022
Q4 | $3.45M | Buy |
87,275
+3,657
| +4% | +$144K | 0.05% | 412 |
|
|
2022
Q3 | $3.36M | Buy |
83,618
+8,041
| +11% | +$323K | 0.05% | 392 |
|
|
2022
Q2 | $3.18M | Hold |
75,577
| – | – | 0.03% | 473 |
|
|
2022
Q1 | $2.94M | Buy |
75,577
+37,003
| +96% | +$1.44M | 0.02% | 530 |
|
|
2021
Q4 | $1.54M | Hold |
38,574
| – | – | 0.01% | 664 |
|
|
2021
Q3 | $1.39M | Buy |
+38,574
| New | +$1.39M | 0.01% | 676 |
|